GUJARAT THEMIS BIOSYN LTD. - 506879 - Financial Results For The Quarter Ended 31St December, 2023
Please refer the attachment10-02-2024
10-02-2024
GUJARAT THEMIS BIOSYN LTD. - 506879 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Pursuant to Regulation 30 of the Listing Regulations, this is to inform you that the Board of Directors of the Company, at its meeting held today i.e. on Saturday, 10th February, 2024, has inter-alia approved the following: a) The Unaudited Standalone Financial Results for the Quarter ended 31st December, 2023. A copy of Unaudited Standalone Financial Results for the Quarter ended 31st December, 2023 together with Limited Review Report is enclosed herewith. b) Declaration of an Interim Dividend for the Financial Year 2023-24 of ? 0.75/- (Rupee Seventy-Five paise only) per equity share having face value of ? 1/- i.e. 75.00% aggregating to ? 5,44,82,632.50/- (Rupees Five Crore Forty-Four Lakhs Eighty-Two Thousand Six Hundred and Thirty-Two and Fifty Paise only) c) The Record Date for the purpose of interim dividend is 22nd February, 2024.10-02-2024
GUJARAT THEMIS BIOSYN LTD. - 506879 - Update on board meeting
GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve Update on board meeting - Further to our communication dated 29th January, 2024, intimating you that the Board of Directors of the Company in its meeting scheduled to be held on 10th February, 2024 will interalia consider and approve the un-financial results for the quarter ended 31st December, 2023, we hereby intimate you that the Board of Directors at the said meeting, is also likely to consider declaration of Interim Dividend for the financial year 2023-24. Further, the Board will also decide about the "Record Date' for the purpose of ascertaining the eligibility of shareholders for payment of said Interim Dividend for the financial year 2023-24, if declared by the Board in its meeting scheduled to be held on 10th February, 2024.07-02-2024
GUJARAT THEMIS BIOSYN LTD. - 506879 - Corporate Action-Board to consider Dividend
The Board of Directors of the Company in its meeting scheduled to be held on 10th February, 2024 for approval of un-audited financial statements for the quarter ended 31st Dec, 2023, may likely to consider declaration of Interim Dividend for the financial year 2023-24. For further information, please refer the attached intimation.07-02-2024
GUJARAT THEMIS BIOSYN LTD. - 506879 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results For The Quarter Ended On 31St December, 2023.
GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve Un-audited Financial Results for the quarter ended on 31st December, 2023.29-01-2024
GUJARAT THEMIS BIOSYN LTD. - 506879 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find our intimation on the captioned subject.08-01-2024
GUJARAT THEMIS BIOSYN LTD. - 506879 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group India Ltd29-12-2023
GUJARAT THEMIS BIOSYN LTD. - 506879 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group India Ltd29-12-2023
GUJARAT THEMIS BIOSYN LTD. - 506879 - Intimation Of Cessation Of Status As 'Subsidiary Company'
As per the attachment.28-12-2023
GUJARAT THEMIS BIOSYN LTD. - 506879 - Closure of Trading Window
Please find our communication on the captioned subject.27-12-2023